The role of endogenous cannabinoids in the hypothalamo-pituitary-adrenal axis regulation: in vivo and in vitro studies in CB1 receptor knockout mice.
Barna
I
I
Institute of Experimental Medicine, 1083 Budapest, P.O. Box 67, Hungary. barna@koki.hu
Zelena
D
D
Arszovszki
A C
AC
Ledent
C
C
D000324:Adrenocorticotropic Hormone / Q000097:blood / Q000378:metabolism; D000704:Analysis of Variance; D000818:Animals; D048588:Benzoxazines; D063385:Cannabinoid Receptor Modulators / Q000819:agonists / Q000494:pharmacology*; D003345:Corticosterone / Q000097:blood / Q000378:metabolism; D003346:Corticotropin-Releasing Hormone / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D007030:Hypothalamo-Hypophyseal System / Q000187:drug effects*; D051379:Mice; D018345:Mice, Knockout; D009025:Morpholines / Q000494:pharmacology; D009281:Naphthalenes / Q000494:pharmacology; D010902:Pituitary Gland / Q000187:drug effects* / Q000378:metabolism; D010913:Pituitary-Adrenal System / Q000187:drug effects*; D011863:Radioimmunoassay; D043884:Receptor, Cannabinoid, CB1 / Q000172:deficiency / Q000235:genetics; D013997:Time Factors
D048588:Benzoxazines; D063385:Cannabinoid Receptor Modulators; D009025:Morpholines; D009281:Naphthalenes; D043884:Receptor, Cannabinoid, CB1; C070417:(3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone; D000324:Adrenocorticotropic Hormone; D003346:Corticotropin-Releasing Hormone; D003345:Corticosterone